Outside of specialized centers, access to the appropriate typing and studies for risk stratification as well as novel therapeutic options is still suboptimal. During this workshop the presenters will review the strategies to achieve an early and adequate diagnosis. The role of autologous transplantation will be discussed, with a focus on Latin America, where access to novel drugs is not universal. Finally, the impact of daratumumab treatment and its place in the therapeutic algorithm will be analyzed. Presentations will be followed by 15 minutes of Q&A and discussion.
Proper management of patients with AL amyloidosis requires a multidisciplinary team. This workshop will be aimed at all those who participate in the management of patients with AL amyloidosis, particularly hematologists, cardiologists, neurologists, nephrologists, pathologists, laboratory specialists and stem cell transplant physicians.
Date & Time:
Wednesday, November 10, 2021
5 PM EDT, 2 PM PDT, 4 PM CDT, 7 PM BRT, 7 PM UYT, 10 PM BST, 11 PM CET, 12 Midnight EEST, 7 AM JST, 9 AM AEST
This event has ended.